So you are discounting the multiple SD and PR achieved as well early in Ph1 clinical trial?? Getting any CR in Ph1 clinical trial let alone so early is excellent (you not only don't know why Azer-Cel was acquired but also don't know the purpose of Ph1 clinical trial like @StrayCatBlues). How about you just wait for the next clinical trial update for VAXINIA at higher dosage or OASIS as maybe these solid tumour does need CD19 to target them more effectively which is why LC has been so "excited"
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.13M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.1¢ | $338.0K | 30.69M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 3480808 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 10994115 | 28 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |